Biopol Chemicals Limited (NSE:BIOPOL)
India flag India · Delayed Price · Currency is INR
46.50
0.00 (0.00%)
At close: Nov 13, 2026

Biopol Chemicals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingSep '26 Mar '26 Mar '25 Mar '24
Revenue
946.78811.43492.21174.33
Revenue Growth
-64.85%182.35%-
Gross Profit
223.03180.1789.1827.91
Operating Income
169.95134.2763.9218.38
Net Income
113.4689.7443.1212.81
Earnings Per Share
11.6510.835.45-
EPS Growth
-98.72%--

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingSep '26 Mar '26 Mar '25 Mar '24
Cash & Investments
1.055.1811.480.82
Total Debt
179.6484.6576.8535.77
Net Cash (Debt)
-178.59-79.47-65.37-34.94
Net Cash Growth
----
Net Cash Per Share
-18.34-9.59-8.26-

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingSep '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
-54.3-127.66-24.14-88.72
Capital Expenditures
-249.15-142-0.24-0.71
Free Cash Flow
-303.45-269.66-24.38-89.43
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingSep '26 Mar '26 Mar '25 Mar '24
Gross Margin
23.56%22.20%18.12%16.01%
Operating Margin
17.95%16.55%12.99%10.54%
Pretax Margin
16.25%14.86%11.74%9.82%
Profit Margin
11.98%11.06%8.76%7.35%
FCF Margin
-32.05%-33.23%-4.95%-51.30%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingNov '26 Mar '26 Mar '25 Mar '24
PE Ratio
3.9911.69--
PS Ratio
0.531.29--